Am J Psychiatry 1984; 141:1356-1364
Copyright © 1984 by American Psychiatric Association
A new rating scale for Alzheimer's disease
WG Rosen, RC Mohs and KL Davis
A new rating instrument, the Alzheimer's Disease Assessment Scale, was
designed specifically to evaluate the severity of cognitive and
noncognitive behavioral dysfunctions characteristic of persons with
Alzheimer's disease. Item descriptions, administration procedures, and
scoring are outlined. Twenty-seven subjects with Alzheimer's disease and 28
normal elderly subjects were rated on 40 items. Twenty-one items with
significant intraclass correlation coefficients for interrater reliability
(range, .650-.989) and significant Spearman rank-order correlation
coefficients for test-retest reliability (range, .514-1) constitute the
final scale. Subjects with Alzheimer's disease had significantly more
cognitive and noncognitive dysfunction than the normal elderly subjects.
This article has been cited by other articles:
|
|
|
|
 
Y.-L. Chang, M. W. Jacobson, C. Fennema-Notestine, D. J. Hagler Jr, R. G. Jennings, A. M. Dale, L. K. McEvoy, and Alzheimer's Disease Neuroimaging Initiative
Level of Executive Function Influences Verbal Memory in Amnestic Mild Cognitive Impairment and Predicts Prefrontal and Posterior Cingulate Thickness
Cereb Cortex,
September 23, 2009;
(2009)
bhp192v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Pilotto, M. Franceschi, G. D'Onofrio, A. Bizzarro, F. Mangialasche, L. Cascavilla, F. Paris, M. G. Matera, A. Pilotto, A. Daniele, et al.
Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease
Neurology,
September 8, 2009;
73(10):
761 - 767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, and V. H. Perry
Systemic inflammation and disease progression in Alzheimer disease
Neurology,
September 8, 2009;
73(10):
768 - 774.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Okello, J. Koivunen, P. Edison, H. A. Archer, F. E. Turkheimer, K. Nagren, R. Bullock, Z. Walker, A. Kennedy, N. C. Fox, et al.
Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study
Neurology,
September 8, 2009;
73(10):
754 - 760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Hamilton, S Fay, and K Rockwood
Misplacing objects in mild to moderate Alzheimer's disease: a descriptive analysis from the VISTA clinical trial
J. Neurol. Neurosurg. Psychiatry,
September 1, 2009;
80(9):
960 - 965.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Querbes, F. Aubry, J. Pariente, J.-A. Lotterie, J.-F. Demonet, V. Duret, M. Puel, I. Berry, J.-C. Fort, P. Celsis, et al.
Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve
Brain,
August 1, 2009;
132(8):
2036 - 2047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Saxton, B E Snitz, O L Lopez, D G Ives, L O Dunn, A Fitzpatrick, M C Carlson, S T DeKosky, and for the GEM Study Investigators
Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
J. Neurol. Neurosurg. Psychiatry,
July 1, 2009;
80(7):
737 - 743.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O L Lopez, J T Becker, A S Wahed, J Saxton, R A Sweet, D A Wolk, W Klunk, and S T DeKosky
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
J. Neurol. Neurosurg. Psychiatry,
June 1, 2009;
80(6):
600 - 607.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Bosch-Domenech, R. Nagel, and J. V. Sanchez-Andres
Prosocial Capabilities in Alzheimer's Patients
J Gerontol B Psychol Sci Soc Sci,
May 25, 2009;
(2009)
gbp034v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Smith
Treatment of Alzheimer's disease in the long-term-care setting
Am. J. Health Syst. Pharm.,
May 15, 2009;
66(10):
899 - 907.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Kolstoe, B. H. Ridha, V. Bellotti, N. Wang, C. V. Robinson, S. J. Crutch, G. Keir, R. Kukkastenvehmas, J. R. Gallimore, W. L. Hutchinson, et al.
Molecular dissection of Alzheimer's disease neuropathology by depletion of serum amyloid P component
PNAS,
May 5, 2009;
106(18):
7619 - 7623.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. Doody, S. H. Ferris, S. Salloway, Y. Sun, R. Goldman, W. E. Watkins, Y. Xu, and A. K. Murthy
Donepezil treatment of patients with MCI: A 48-week randomized, placebo-controlled trial
Neurology,
May 5, 2009;
72(18):
1555 - 1561.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. L. Lanctot, R. D. Rajaram, and N. Herrmann
Review: Therapy for Alzheimer's disease: how effective are current treatments?
Therapeutic Advances in Neurological Disorders,
May 1, 2009;
2(3):
163 - 180.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S Benisty, A A Gouw, R Porcher, S Madureira, K Hernandez, A Poggesi, W M van der Flier, E C W Van Straaten, A Verdelho, J Ferro, et al.
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study
J. Neurol. Neurosurg. Psychiatry,
May 1, 2009;
80(5):
478 - 483.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Minati, T. Edginton, M. Grazia Bruzzone, and G. Giaccone
Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review
American Journal of Alzheimer's Disease and Other Dementias,
April 1, 2009;
24(2):
95 - 121.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. S. Smith, E. Kramer, Y. Ma, C. R. Hermann, V. Dhawan, T. Chaly, and D. Eidelberg
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease
Brain,
February 1, 2009;
132(2):
392 - 401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tangwongchai, N. Thavichachart, V. Senanarong, N. Poungvarin, K. Phanthumchinda, R. Praditsuwan, S. Nidhinandana, and S. Chankrachang
Galantamine for the Treatment of BPSD in Thai Patients With Possible Alzheimer's Disease With or Without Cerebrovascular Disease
American Journal of Alzheimer's Disease and Other Dementias,
January 1, 2009;
23(6):
593 - 601.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. J. Sevigny, J. M. Ryan, C. H. van Dyck, Y. Peng, C. R. Lines, M. L. Nessly, and On behalf of the MK-677 Protocol 30 Study Group
Growth hormone secretagogue MK-677: No clinical effect on AD progression in a randomized trial
Neurology,
November 18, 2008;
71(21):
1702 - 1708.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. B. Hogan MD, P. Bailey MD, S. Black MD, A. Carswell MSc PhD, H. Chertkow MD, B. Clarke MD, C. Cohen BA MD, J. D. Fisk PhD, D. Forbes RN PhD, M. Man-Son-Hing MSc MD, et al.
Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia
Can. Med. Assoc. J.,
November 4, 2008;
179(10):
1019 - 1026.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H. Dodge, Y. Kita, H. Takechi, T. Hayakawa, M. Ganguli, and H. Ueshima
Healthy Cognitive Aging and Leisure Activities Among the Oldest Old in Japan: Takashima Study
J. Gerontol. A Biol. Sci. Med. Sci.,
November 1, 2008;
63(11):
1193 - 1200.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Jalbert, L. A. Daiello, and K. L. Lapane
Dementia of the Alzheimer Type
Epidemiol. Rev.,
November 1, 2008;
30(1):
15 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Aisen, L. S. Schneider, M. Sano, R. Diaz-Arrastia, C. H. van Dyck, M. F. Weiner, T. Bottiglieri, S. Jin, K. T. Stokes, R. G. Thomas, et al.
High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer Disease: A Randomized Controlled Trial
JAMA,
October 15, 2008;
300(15):
1774 - 1783.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Palmqvist, O. Hansson, L. Minthon, and E. Londos
The Usefulness of Cube Copying for Evaluating Treatment of Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias,
October 1, 2008;
23(5):
439 - 446.
[Abstract]
[PDF]
|
|
|
|
|
|
|
N. T. Lautenschlager, K. L. Cox, L. Flicker, J. K. Foster, F. M. van Bockxmeer, J. Xiao, K. R. Greenop, and O. P. Almeida
Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease: A Randomized Trial
JAMA,
September 3, 2008;
300(9):
1027 - 1037.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Erkinjuntti, S. Gauthier, R. Bullock, A. Kurz, G. Hammond, S. Schwalen, Y. Zhu, and R. Brashear
Galantamine treatment in Alzheimer's disease with cerebrovascular disease: responder analyses from a randomized, controlled trial (GAL-INT-6)
J Psychopharmacol,
September 1, 2008;
22(7):
761 - 768.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. M. Nestor, R. Rupsingh, M. Borrie, M. Smith, V. Accomazzi, J. L. Wells, J. Fogarty, R. Bartha, and the Alzheimer's Disease Neuroimaging Initiative
Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database
Brain,
September 1, 2008;
131(9):
2443 - 2454.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Ferrucci, F. Mameli, I. Guidi, S. Mrakic-Sposta, M. Vergari, S. Marceglia, F. Cogiamanian, S. Barbieri, E. Scarpini, and A. Priori
Transcranial direct current stimulation improves recognition memory in Alzheimer disease
Neurology,
August 12, 2008;
71(7):
493 - 498.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B Miranda, S Madureira, A Verdelho, J Ferro, L Pantoni, E Salvadori, H Chabriat, T Erkinjuntti, F Fazekas, M Hennerici, et al.
Self-perceived memory impairment and cognitive performance in an elderly independent population with age-related white matter changes
J. Neurol. Neurosurg. Psychiatry,
August 1, 2008;
79(8):
869 - 873.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Sultzer, S. M. Davis, P. N. Tariot, K. S. Dagerman, B. D. Lebowitz, C. G. Lyketsos, R. A. Rosenheck, J. K. Hsiao, J. A. Lieberman, L. S. Schneider, et al.
Clinical Symptom Responses to Atypical Antipsychotic Medications in Alzheimer's Disease: Phase 1 Outcomes From the CATIE-AD Effectiveness Trial
Am J Psychiatry,
July 1, 2008;
165(7):
844 - 854.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Modrego, I. Monleon, and M. Sarasa
The Clinical Significance of Plasmatic Amyloid A{beta}-40 Peptide Levels in Alzheimer's Disease Patients Treated With Galantamine
American Journal of Alzheimer's Disease and Other Dementias,
June 1, 2008;
23(3):
286 - 290.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Winblad, S. Gauthier, L. Scinto, H. Feldman, G. K. Wilcock, L. Truyen, A. J. Mayorga, D. Wang, H. R. Brashear, J. S. Nye, et al.
Safety and efficacy of galantamine in subjects with mild cognitive impairment
Neurology,
May 27, 2008;
70(22):
2024 - 2035.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M Suenaga, Y Kawai, H Watanabe, N Atsuta, M Ito, F Tanaka, M Katsuno, H Fukatsu, S Naganawa, and G Sobue
Cognitive impairment in spinocerebellar ataxia type 6
J. Neurol. Neurosurg. Psychiatry,
May 1, 2008;
79(5):
496 - 499.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Raina, P. Santaguida, A. Ismaila, C. Patterson, D. Cowan, M. Levine, L. Booker, and M. Oremus
Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline
Ann Intern Med,
March 4, 2008;
148(5):
379 - 397.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. Modrego, C. Rios, J. M. Perez Trullen, J. M. Errea, M. J. Garcia-Gomara, and S. Sanchez
The Cerebrovascular Pathology in Alzheimer's Disease and Its Influence on Clinical Variables
American Journal of Alzheimer's Disease and Other Dementias,
March 1, 2008;
23(1):
91 - 96.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J Warner, R McCarney, M Griffin, K Hill, and P Fisher
Participation in dementia research: rates and correlates of capacity to give informed consent
J. Med. Ethics,
March 1, 2008;
34(3):
167 - 170.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Bonanni, A. Thomas, P. Tiraboschi, B. Perfetti, S. Varanese, and M. Onofrj
EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up
Brain,
March 1, 2008;
131(3):
690 - 705.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Fleisher, S. Sun, C. Taylor, C. P. Ward, A. C. Gamst, R. C. Petersen, C. R. Jack Jr, P. S. Aisen, L. J. Thal, and For the Alzheimer's Disease Cooperative Study
Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment
Neurology,
January 15, 2008;
70(3):
191 - 199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Alley, E. M. Crimmins, A. Karlamangla, P. Hu, and T. E. Seeman
Inflammation and Rate of Cognitive Change in High-Functioning Older Adults
J. Gerontol. A Biol. Sci. Med. Sci.,
January 1, 2008;
63(1):
50 - 55.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. C. Dickerson, R. A. Sperling, B. T. Hyman, M. S. Albert, and D. Blacker
Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment
Arch Gen Psychiatry,
December 1, 2007;
64(12):
1443 - 1450.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Bastos-Leite, W. M. van der Flier, E. C.W. van Straaten, S. S. Staekenborg, P. Scheltens, and F. Barkhof
The Contribution of Medial Temporal Lobe Atrophy and Vascular Pathology to Cognitive Impairment in Vascular Dementia
Stroke,
December 1, 2007;
38(12):
3182 - 3185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. L. Tyas, D. A. Snowdon, M. F. Desrosiers, K. P. Riley, and W. R. Markesbery
Healthy ageing in the Nun Study: definition and neuropathologic correlates
Age Ageing,
November 1, 2007;
36(6):
650 - 655.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. van de Pol, W. M. van der Flier, E.S.C. Korf, N. C. Fox, F. Barkhof, and P. Scheltens
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment
Neurology,
October 9, 2007;
69(15):
1491 - 1497.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Bronnick, M. Emre, R. Lane, S. Tekin, and D. Aarsland
Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2007;
78(10):
1064 - 1068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H Feldman, R. Lane, and on behalf of the Study 304 Group
Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2007;
78(10):
1056 - 1063.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Allen, H. Barnard, R. McColl, A. L. Hester, J. A. Fields, M. F. Weiner, W. K. Ringe, A. M. Lipton, M. Brooker, E. McDonald, et al.
Reduced Hippocampal Functional Connectivity in Alzheimer Disease
Arch Neurol,
October 1, 2007;
64(10):
1482 - 1487.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-F. Y. Lu, M. G. Austrom, S. M. Perkins, T. Bakas, M. R. Farlow, Feng He, Shelia Jin, and A. Gamst
Depressed Mood in Informal Caregivers of Individuals With Mild Cognitive Impairment
American Journal of Alzheimer's Disease and Other Dementias,
September 1, 2007;
22(4):
273 - 285.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Gregory, F. Roked, L. Jones, and A. Patel
Is the degree of cognitive impairment in patients with Alzheimer's disease related to their capacity to appoint an enduring power of attorney?
Age Ageing,
September 1, 2007;
36(5):
527 - 531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Auchus, H. R. Brashear, S. Salloway, A. D. Korczyn, P. P. De Deyn, C. Gassmann-Mayer, and For the GAL-INT-26 Study Group
Galantamine treatment of vascular dementia: A randomized trial
Neurology,
July 31, 2007;
69(5):
448 - 458.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Winblad, G. Grossberg, L. Frolich, M. Farlow, S. Zechner, J. Nagel, and R. Lane
IDEAL: A 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease
Neurology,
July 24, 2007;
69(4_suppl_1):
S14 - S22.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. A. van de Pol, E. S. C. Korf, W. M. van der Flier, H. R. Brashear, N. C. Fox, F. Barkhof, and P. Scheltens
Magnetic Resonance Imaging Predictors of Cognition in Mild Cognitive Impairment
Arch Neurol,
July 1, 2007;
64(7):
1023 - 1028.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Gelfanova, R. E. Higgs, R. A. Dean, D. M. Holtzman, M. R. Farlow, E. R. Siemers, A. Boodhoo, Y.-W. Qian, X. He, Z. Jin, et al.
Quantitative analysis of amyloid-{beta} peptides in cerebrospinal fluid using immunoprecipitation and MALDI-Tof mass spectrometry
Brief Funct Genomic Proteomic,
June 20, 2007;
(2007)
elm010v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Fleisher, B. B. Sowell, C. Taylor, A. C. Gamst, R. C. Petersen, L. J. Thal, and for the Alzheimer's Disease Cooperative Study
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment
Neurology,
May 8, 2007;
68(19):
1588 - 1595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Rockwood, S. Fay, P. Jarrett, and E. Asp
Effect of galantamine on verbal repetition in AD: A secondary analysis of the VISTA trial
Neurology,
April 3, 2007;
68(14):
1116 - 1121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Edison, H. A. Archer, R. Hinz, A. Hammers, N. Pavese, Y. F. Tai, G. Hotton, D. Cutler, N. Fox, A. Kennedy, et al.
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
Neurology,
February 13, 2007;
68(7):
501 - 508.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. T. Blaszczyk and M. Mathys
Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia
Journal of Pharmacy Practice,
February 1, 2007;
20(1):
13 - 28.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. M. Balk, G. Raman, A. Tatsioni, M. Chung, J. Lau, and I. H. Rosenberg
Vitamin B6, B12, and Folic Acid Supplementation and Cognitive Function: A Systematic Review of Randomized Trials
Arch Intern Med,
January 8, 2007;
167(1):
21 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Inzitari, M. Simoni, G. Pracucci, A. Poggesi, A. M. Basile, H. Chabriat, T. Erkinjuntti, F. Fazekas, J. M. Ferro, M. Hennerici, et al.
Risk of Rapid Global Functional Decline in Elderly Patients With Severe Cerebral Age-Related White Matter Changes: The LADIS Study
Arch Intern Med,
January 8, 2007;
167(1):
81 - 88.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G Livingston, A E Walker, C L E Katona, and C Cooper
Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study
J. Neurol. Neurosurg. Psychiatry,
January 1, 2007;
78(1):
25 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Nagahama, T. Okina, N. Suzuki, and M. Matsuda
The cambridge behavioral inventory: validation and application in a memory clinic.
J Geriatr Psychiatry Neurol,
December 1, 2006;
19(4):
220 - 225.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F. Chiappelli, A. M. Navarro, D. R. Moradi, E. Manfrini, and P. Prolo
Evidence-Based Research in Complementary and Alternative Medicine III: Treatment of Patients with Alzheimer's Disease
Evid. Based Complement. Altern. Med.,
December 1, 2006;
3(4):
411 - 424.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H. Dodge, Y. Du, J. A. Saxton, and M. Ganguli
Cognitive Domains and Trajectories of Functional Independence in Nondemented Elderly Persons
J. Gerontol. A Biol. Sci. Med. Sci.,
December 1, 2006;
61(12):
1330 - 1337.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Aisen, D. Saumier, R. Briand, J. Laurin, F. Gervais, P. Tremblay, and D. Garceau
A Phase II study targeting amyloid-{beta} with 3APS in mild-to-moderate Alzheimer disease
Neurology,
November 28, 2006;
67(10):
1757 - 1763.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K Bronnick, U Ehrt, M Emre, P P De Deyn, K Wesnes, S Tekin, and D Aarsland
Attentional deficits affect activities of daily living in dementia-associated with Parkinson's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2006;
77(10):
1136 - 1142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Tarraga, M Boada, G Modinos, A Espinosa, S Diego, A Morera, M Guitart, J Balcells, O L Lopez, and J T Becker
A randomised pilot study to assess the efficacy of an interactive, multimedia tool of cognitive stimulation in Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry,
October 1, 2006;
77(10):
1116 - 1121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. R. Farlow
Use of Antidementia Agents in Vascular Dementia: Beyond Alzheimer Disease
Mayo Clin. Proc.,
October 1, 2006;
81(10):
1350 - 1358.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tsolaki, A. Alexiadou, G. Kiosseoglou, and F. Kounti
Correlations between the Functional-Cognitive Assessment Scale and the Alzheimer's Disease Assessment Scale when administered to patients with dementia residing in long-term care.
American Journal of Alzheimer's Disease and Other Dementias,
August 1, 2006;
21(4):
274 - 280.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. KNAPP, L. THORGRIMSEN, A. PATEL, A. SPECTOR, A. HALLAM, B. WOODS, and M. ORRELL
Cognitive stimulation therapy for people with dementia: cost-effectiveness analysis
The British Journal of Psychiatry,
June 1, 2006;
188(6):
574 - 580.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Rockwood, S. Fay, X. Song, C. MacKnight, M. Gorman, and on behalf of the Video-Imaging Synthesis of Treati
Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial
Can. Med. Assoc. J.,
April 11, 2006;
174(8):
1099 - 1105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ganguli, Y. Du, H. H. Dodge, G. G. Ratcliff, and C.-C. H. Chang
Depressive Symptoms and Cognitive Decline in Late Life: A Prospective Epidemiological Study
Arch Gen Psychiatry,
February 1, 2006;
63(2):
153 - 160.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. H. Lu, D. A. Masterman, R. Mulnard, C. Cotman, B. Miller, K. Yaffe, E. Reback, V. Porter, R. Swerdloff, and J. L. Cummings
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men
Arch Neurol,
February 1, 2006;
63(2):
177 - 185.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Bastos Leite, W. M. van der Flier, E. C. W. van Straaten, P. Scheltens, and F. Barkhof
Infratentorial Abnormalities in Vascular Dementia
Stroke,
January 1, 2006;
37(1):
105 - 110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sacuiu, M. Sjogren, B. Johansson, D. Gustafson, and I. Skoog
Prodromal cognitive signs of dementia in 85-year-olds using four sources of information
Neurology,
December 27, 2005;
65(12):
1894 - 1900.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R Overshott and A Burns
Treatment of dementia
J. Neurol. Neurosurg. Psychiatry,
December 1, 2005;
76(suppl_5):
v53 - v59.
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. ONDER, O. ZANETTI, E. GIACOBINI, G. B. FRISONI, L. BARTORELLI, G. CARBONE, P. LAMBERTUCCI, M. C. SILVERI, and R. BERNABEI
Reality orientation therapy combined with cholinesterase inhibitors in Alzheimer's disease: randomised controlled trial
The British Journal of Psychiatry,
November 1, 2005;
187(5):
450 - 455.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ganguli, J. V. Bilt, J. A. Saxton, C. Shen, and H. H. Dodge
Alcohol consumption and cognitive function in late life: A longitudinal community study
Neurology,
October 25, 2005;
65(8):
1210 - 1217.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Xiong, K. Yu, F. Gao, Y. Yan, and Z. Zhang
Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial
Clinical Trials,
October 1, 2005;
2(5):
387 - 393.
[Abstract]
[PDF]
|
|
|
|
|
|
|
W. M. van der Flier, E. C.W. van Straaten, F. Barkhof, A. Verdelho, S. Madureira, L. Pantoni, D. Inzitari, T. Erkinjuntti, M. Crisby, G. Waldemar, et al.
Small Vessel Disease and General Cognitive Function in Nondisabled Elderly: The LADIS Study
Stroke,
October 1, 2005;
36(10):
2116 - 2120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. H. Feldman and M. Woodward
The staging and assessment of moderate to severe Alzheimer disease
Neurology,
September 27, 2005;
65(6_suppl_3):
S10 - S17.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
H. Kaduszkiewicz, T. Zimmermann, H.-P. Beck-Bornholdt, and H. van den Bussche
Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials
BMJ,
August 6, 2005;
331(7512):
321 - 327.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. J. Chandler, L. H. Lacritz, L. S. Hynan, H. D. Barnard, G. Allen, M. Deschner, M. F. Weiner, and C. M. Cullum
A total score for the CERAD neuropsychological battery
Neurology,
July 12, 2005;
65(1):
102 - 106.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Gilman, M. Koller, R. S. Black, L. Jenkins, S. G. Griffith, N. C. Fox, L. Eisner, L. Kirby, M. B. Rovira, F. Forette, et al.
Clinical effects of A{beta} immunization (AN1792) in patients with AD in an interrupted trial
Neurology,
May 10, 2005;
64(9):
1553 - 1562.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. S. Mega, I. D. Dinov, V. Porter, G. Chow, E. Reback, P. Davoodi, S. M. O'Connor, M. F. Carter, H. Amezcua, and J. L. Cummings
Metabolic Patterns Associated With the Clinical Response to Galantamine Therapy: A Fludeoxyglucose F 18 Positron Emission Tomographic Study
Arch Neurol,
May 1, 2005;
62(5):
721 - 728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. L. Sparks, M. N. Sabbagh, D. J. Connor, J. Lopez, L. J. Launer, P. Browne, D. Wasser, S. Johnson-Traver, J. Lochhead, and C. Ziolwolski
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease: Preliminary Results
Arch Neurol,
May 1, 2005;
62(5):
753 - 757.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Ellis
Cholinesterase Inhibitors in the Treatment of Dementia
J Am Osteopath Assoc,
March 1, 2005;
105(3):
145 - 158.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. E. Seeman, M.-H. Huang, P. Bretsky, E. Crimmins, L. Launer, and J. M. Guralnik
Education and APOE-e4 in Longitudinal Cognitive Decline: MacArthur Studies of Successful Aging
J. Gerontol. B. Psychol. Sci. Soc. Sci.,
March 1, 2005;
60(2):
P74 - P83.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Ikonomovic, E. J. Mufson, J. Wuu, D. A. Bennett, and S. T. DeKosky
Reduction of Choline Acetyltransferase Activity in Primary Visual Cortex in Mild to Moderate Alzheimer's Disease
Arch Neurol,
March 1, 2005;
62(3):
425 - 430.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. COCHRANE, A. COCHRANE, P. JAUHAR, and E. ASHTON
ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF WERNICKE-KORSAKOFF SYNDROME-THREE FURTHER CASES SHOW RESPONSE TO DONEPEZIL
Alcohol Alcohol.,
March 1, 2005;
40(2):
151 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Bayer, R. Bullock, R. W. Jones, D. Wilkinson, K. R. Paterson, L. Jenkins, S. B. Millais, and S. Donoghue
Evaluation of the safety and immunogenicity of synthetic A{beta}42 (AN1792) in patients with AD
Neurology,
January 11, 2005;
64(1):
94 - 101.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Olazaran, R. Muniz, B. Reisberg, J. Pena-Casanova, T. del Ser, A. J. Cruz-Jentoft, P. Serrano, E. Navarro, M. L. Garcia de la Rocha, A. Frank, et al.
Benefits of cognitive-motor intervention in MCI and mild to moderate Alzheimer disease
Neurology,
December 28, 2004;
63(12):
2348 - 2353.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Emre, D. Aarsland, A. Albanese, E. J. Byrne, G. Deuschl, P. P. De Deyn, F. Durif, J. Kulisevsky, T. van Laar, A. Lees, et al.
Rivastigmine for Dementia Associated with Parkinson's Disease
N. Engl. J. Med.,
December 9, 2004;
351(24):
2509 - 2518.
[Abstract]
[Full Text]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1984
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
